戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rin for thromboprophylaxis after hip or knee arthroplasty.
2 g complications that hinder the merits of an arthroplasty.
3 enoxaparin in patients undergoing total knee arthroplasty.
4  factors for infection following total joint arthroplasty.
5 gnosis of invasive SSI following hip vs knee arthroplasty.
6 ollowing knee arthroplasty compared with hip arthroplasty.
7 on is a major complication after total joint arthroplasty.
8 association between statin exposure and knee arthroplasty.
9  with late infection of his right total knee arthroplasty.
10 ue culture obtained at revision or resection arthroplasty.
11 is the most frequent medical complication of arthroplasty.
12 asty and 0.26% (95% CI, 0.14%-0.37%) for hip arthroplasty.
13 asty and 0.14% (95% CI, 0.07%-0.21%) for hip arthroplasty.
14 and 348,596 who underwent revision total hip arthroplasty.
15  of DAIR in relation to the time after index arthroplasty.
16 e timing of orthopedic interventions such as arthroplasty.
17 ided hip pain, before and 9 months after hip arthroplasty.
18 e was obtained from patients undergoing knee arthroplasty.
19 tic events, in patients undergoing total hip arthroplasty.
20 tion is seen within the first 6 months after arthroplasty.
21 within 2 years of diagnosis and 50% required arthroplasty.
22  as well as patients undergoing elective hip arthroplasty.
23 s and outcomes of joint surface collapse and arthroplasty.
24 ed to study the mortality outcomes following arthroplasty.
25 reduction and internal fixation, or previous arthroplasty.
26 undergoing hip or knee revision or resection arthroplasty.
27 ne was used in patients undergoing total hip arthroplasty.
28 tween minimal and standard incisions for hip arthroplasty.
29 and morbidity following elective knee or hip arthroplasty.
30  both inflammatory arthritis and total joint arthroplasty.
31 een ethnic groups are not seen following hip arthroplasty.
32 22, 95% CI 0.63-2.36 in Hispanics) after hip arthroplasty.
33  the trend of increasing rates of total knee arthroplasty.
34 boembolism in patients undergoing total knee arthroplasty.
35 ity in patients undergoing total hip or knee arthroplasty.
36 tion of infection associated with lower limb arthroplasty.
37 ts in the treatment group had undergone knee arthroplasty.
38 embolism within three months after total hip arthroplasty.
39 d from knees of patients who underwent joint arthroplasty.
40 come of DAIR in relation to time after index arthroplasty.
41 in management after total knee and total hip arthroplasty.
42 ) is a catastrophic complication of shoulder arthroplasty.
43 otal Hip Arthroplasty, and 18% in Total Knee Arthroplasty.
44 a, admitted for primary elective hip or knee arthroplasty.
45 on, and 1.33%; (1.13-1.56; 152 patients) for arthroplasty.
46 in management after total knee and total hip arthroplasty.
47 uplex ultrasound approximately 1 month after arthroplasty.
48 l treatments to reduce pain after total knee arthroplasty.
49 y among patients after undergoing total knee arthroplasty.
50 stoperative pain management after total knee arthroplasty.
51 OA-affected joints at the time of total knee arthroplasty.
52  disc and are a viable option for total disc arthroplasty.
53 period, in younger patients, and after joint arthroplasty.
54 dentified; 401 (61%) occurred following knee arthroplasties.
55 erably in the future along with the need for arthroplasties.
56  knee (HR 0.91 [95% CI 0.72-1.15], P = 0.41) arthroplasties.
57 oth groups were cholecystectomy (10.5%), hip arthroplasty (10.5%), spine surgery (9.8%), herniorrhaph
58 hernia repair (26.5%), hysterectomy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypas
59 oups of patients: 14 who were undergoing hip arthroplasty, 28 hemodialysis patients who were particip
60 procedures ranged between 729 855 total knee arthroplasties (47.21%) and 4558 esophagectomies (0.29%)
61          In patients who underwent total hip arthroplasty, a body-mass index of 25 or greater was ass
62 most dreaded complications after total joint arthroplasty, a common procedure in patients with rheuma
63 ough 2000 to determine the incidence of knee arthroplasty according to Hospital Referral Region, sex,
64  significantly shorter for hip than for knee arthroplasties after adjusting for age, pathogen virulen
65 rm decisions about surgical approach for hip arthroplasty, although further research is needed to und
66 there were 679 hip arthroplasties and 7 knee arthroplasties among centenarians in this database.
67 We describe the epidemiology of knee and hip arthroplasties among centenarians using data from a larg
68 here are large variations in the use of knee arthroplasty among Medicare enrollees according to race
69 udied epidemiology and mortality outcomes of arthroplasty among these individuals.
70          Among patients undergoing total hip arthroplasty, an anterior surgical approach compared wit
71                  Overall, there were 679 hip arthroplasties and 7 knee arthroplasties among centenari
72 is known to provoke aseptic loosening around arthroplasties and is associated with implant failures.
73 sm were 0.27% (95% CI, 0.16%-0.38%) for knee arthroplasty and 0.14% (95% CI, 0.07%-0.21%) for hip art
74 VT were 0.63% (95% CI, 0.47%-0.78%) for knee arthroplasty and 0.26% (95% CI, 0.14%-0.37%) for hip art
75 all 30-day mortality was 0.6% following knee arthroplasty and 0.7% following hip arthroplasty, with n
76 reased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001).
77 .3% among the patients assigned to total hip arthroplasty and 13.1% among those assigned to hemiarthr
78  in 34 patients (4.7%) assigned to total hip arthroplasty and 17 patients (2.4%) assigned to hemiarth
79  28 patients with proved infected total knee arthroplasty and 28 patients with noninfected arthroplas
80 eneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision total hi
81 , data on 12,108 patients who underwent knee arthroplasty and 6,703 patients who underwent hip arthro
82 .9%) who were randomly assigned to total hip arthroplasty and 60 of 723 patients (8.3%) who were rand
83 further increased in the setting of revision arthroplasty and a previous prosthetic joint infection.
84 patients with hip or knee osteoarthritis and arthroplasty and analyze the association of these with l
85 se thalamic volume changes reverse after hip arthroplasty and are associated with decreased pain and
86 ections are a devastating complication after arthroplasty and are associated with substantial patient
87 nous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge.
88 ophytic fibrocartilage were obtained at knee arthroplasty and cultured ex vivo with or without IL-1 b
89 observational data on the incidence of joint arthroplasty and disability will help to place the issue
90 injection (MCPI) in patients undergoing knee arthroplasty and evaluate their safety.
91 e lesions in younger patients, none required arthroplasty and four improved.
92 om the tibial plateau of OA knees removed at arthroplasty and from normal, nonarthritic, knees obtain
93 ered by patient sex, with significantly more arthroplasty and fusion procedures performed in women.
94 n 300 patients (41.8%) assigned to total hip arthroplasty and in 265 patients (36.7%) assigned to hem
95 ecting infections associated with lower limb arthroplasty and is more accurate for detecting infectio
96 s older than 10 years, 19 required total hip arthroplasty and none improved.
97  Among older patients undergoing hip or knee arthroplasty and receiving warfarin prophylaxis, an inte
98 s, to guide the child and family through hip arthroplasty and rehabilitation.
99  were randomly assigned to undergo total hip arthroplasty and those who were assigned to undergo hemi
100             Pain management after total knee arthroplasty and total hip arthroplasty is pivotal, as i
101 ong patients undergoing elective hip or knee arthroplasty and treated with perioperative warfarin, ge
102 initiating warfarin for elective hip or knee arthroplasty and was conducted at 6 US medical centers.
103 on (range: 61% for TURP to 88% for total hip arthroplasty), and are thus missed by the ProPublica mea
104 ery bypass grafting (CABG), 19% in Total Hip Arthroplasty, and 18% in Total Knee Arthroplasty.
105 osis surgery, embolic complications of joint arthroplasty, and complications related to the use of op
106 rom 4472 randomly selected cardiac, hip/knee arthroplasty, and hysterectomy cases.
107 as the use of bone morphogenic protein, disk arthroplasty, and interspinous spacers, are seen with in
108 m repair, total hip arthroplasty, total knee arthroplasty, and lung resection were identified.
109  aneurysm (AAA) repair, colectomy, total hip arthroplasty, and pancreatectomy.
110              The procedure codes for fusion, arthroplasty, and tenosynovectomy were matched to patien
111 y, prostatectomy, lung resection, total knee arthroplasty, and total hip arthroplasty-between 2010 an
112                          More than 1 million arthroplasties are done every year worldwide, and this n
113 f infection-related complications after knee arthroplasty are higher in Hispanic patients than in whi
114           In the US population, hip and knee arthroplasty are very rarely performed among centenarian
115 ertainty regarding the effect of a total hip arthroplasty as compared with hemiarthroplasty.
116 ppeared more likely to be isolated as either arthroplasty-associated non-prosthetic joint infection-a
117 were icaA positive, and 30% (7 out of 23) of arthroplasty-associated non-prosthetic joint infection-a
118 tive staphylococci isolated from noninfected arthroplasty-associated specimens were screened in order
119 ema, and intramuscular edema after total hip arthroplasty at 1.5-T MRI with metal artifact reduction
120 initiating warfarin for elective hip or knee arthroplasty at 6 US medical centers.
121 elihood of joint deterioration necessitating arthroplasty at a young age.
122 l spine fusion for myelopathy, or total knee arthroplasty at hospitals in California were abstracted
123 splay the time to joint surface collapse and arthroplasty based on selected predictors.
124 aries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease
125 ion codes for primary and revision total hip arthroplasty between 1991 and 2008.
126 tion, total knee arthroplasty, and total hip arthroplasty-between 2010 and 2014.
127 s of invasive SSI was delayed following knee arthroplasty compared with hip arthroplasty.
128 fection-related complications following knee arthroplasty, compared with white patients.
129 through November 30, 2018: total knee or hip arthroplasty, coronary artery bypass grafting, colectomy
130 CI 7.50-10.15) of 1816 patients had received arthroplasty, corresponding to an annual risk of arthrop
131 nical trials indicate that newer total ankle-arthroplasty designs provide substantial pain relief in
132 lex S. aureus SSIs decreased for hip or knee arthroplasties (difference per 10,000 operations, -17 [9
133  exercise participation prior to total joint arthroplasty dramatically reduces the odds of inpatient
134                                              Arthroplasties due to hip fracture were censored.
135 a for the study were indication for revision arthroplasty due to aseptic implant failure, acute high-
136 e been used in dental implants and total hip arthroplasty due to their excellent biocompatibility.
137 ption analgesic or antiinflammatory use, and arthroplasty during 1 year of followup.
138  having elective inpatient total knee or hip arthroplasty, either primary or revision, and had a rece
139 ection (SSI) is a feared complication in hip arthroplasty, especially following femoral neck fracture
140                        Future demand for hip arthroplasty, especially in patients younger than 65 yea
141 al joints, other surgical procedures such as arthroplasty, excision of painful calcinosis, and digita
142 ndergone a primary revision of a total elbow arthroplasty for aseptic loosening between 1996 and 2008
143  Risk-adjusted mortality estimates following arthroplasty for centenarians were higher than for nonag
144         All subjects had undergone total hip arthroplasty for idiopathic arthritis, and the scans wer
145                     The utilization of joint arthroplasty for knee or hip osteoarthritis varies marke
146  radiographic finding of hip OA or total hip arthroplasty for OA (OR 1.71, 95% CI 1.16-2.52, P = 0.00
147 efit patients after total knee and total hip arthroplasty for pain management.
148 om 66 patients undergoing two-stage revision arthroplasty for PJI submitted for sonication culture, a
149 ing the use of ACSS in a 2-stage hip or knee arthroplasty for treatment of PJI (1988 through August 2
150 4.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001).
151 499 consecutive patients undergoing revision arthroplasty from whom 1,437 periprosthetic tissue sampl
152 hyperintense synovitis at MR imaging of knee arthroplasty had a high sensitivity and specificity for
153 ment approach after total knee and total hip arthroplasty has increasingly become an alternative.
154                 Ethnic differences in use of arthroplasty have been associated with less willingness
155 ts in orthopedic surgery, the results of hip arthroplasty have improved.
156 -ceramic, and techniques such as resurfacing arthroplasty have the potential to improve outcomes and
157                                     Revision arthroplasty (hazard ratio [HR] 2.99, 95% confidence int
158 artery bypass grafting, colectomy, total hip arthroplasty, hip fracture repair, and lumbar spine surg
159 t the personal and societal expense of joint arthroplasty, hospitalizations, disability, and diminish
160 al group, conducted at 2 public, high-volume arthroplasty hospitals in Sydney, Australia (July 2012-D
161 borderline statistically significant for hip arthroplasty (HR 0.73 [95% CI 0.52-1.03], P = 0.07), and
162 therapy had significantly lower rates of any arthroplasty (HR 0.84 [95% CI 0.70-1.00], P = 0.05).
163 03], P = 0.07), and not significant for knee arthroplasty (HR 0.87 [95% CI 0.71-1.07], P = 0.19).
164 in trial, there was no association for total arthroplasty (HR 0.99 [95% CI 0.82-1.20], P = 0.92) or f
165 d no association between statin use and knee arthroplasty (HR, 1.04; 95% CI, .99-1.09).
166 ry types and was strongest after total joint arthroplasty (HR, 3.79; 95% CI, 3.21-4.47 for hip replac
167 issues from people with metal-on-polymer hip arthroplasties, immunohistochemically.
168        Twenty-three patients (29%) underwent arthroplasty in 36 hips at a mean of 1.3 years (range, 0
169 my, thoracic surgery, and total knee and hip arthroplasty in a single-center prospective observationa
170  decrease in the rates of primary total knee arthroplasty in patients with RA.
171 te to the increased infection risk following arthroplasty in patients with T2D and obesity.
172  viable solution to prevent infections after arthroplasty in uncemented prosthetic devices and, simul
173 urgical diagnosis (hip fracture treated with arthroplasty) in 2010.
174 ge for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for r
175  to our knowledge, the first case of S. suis arthroplasty infection and streptococcal toxic shock-lik
176 during second stages of staged revisions for arthroplasty infection.
177 implantation for staged revision of infected arthroplasties is challenging.
178                                    Total hip arthroplasty is a common surgical procedure but little i
179                                    Total hip arthroplasty is a cost-effective surgical procedure unde
180                                   Cementless arthroplasty is a promising replacement strategy in adol
181 ve staphylococcal isolate associated with an arthroplasty is not a useful diagnostic indicator of pat
182  after total knee arthroplasty and total hip arthroplasty is pivotal, as it determines the outcome of
183 TE) in warfarin-treated patients with recent arthroplasty is unknown.
184 agatran started the morning after total knee arthroplasty is well tolerated and at least as effective
185                        For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days
186 ear to differ significantly in terms of post-arthroplasty mortality rates.
187 matic venous thromboembolism after total hip arthroplasty most commonly develops after the patient is
188    For patients undergoing revision shoulder arthroplasty, multiple samples from the surgical field w
189  to failed Metal-on-Polymer articulating hip arthroplasties (n = 10).
190 ts (n = 54) who developed delirium following arthroplasty (n = 28) and those who did not (n = 26).
191 rgery (fracture groups, n = 33) or total hip arthroplasty (nonfracture groups, n = 17).
192 RA who required unilateral sialastic implant arthroplasty of the 2nd-5th metacarpophalangeal (MCP) jo
193                                              Arthroplasty of the knee and hip have been successful in
194 ecision and choice of antibiotics in routine arthroplasties or PJI's.
195 al neck fracture to undergo either total hip arthroplasty or hemiarthroplasty.
196 ed as a pathogen in foreign-body infections (arthroplasty or spinal instrumentation).
197 lished race/ethnicity-specific data on joint arthroplasty outcomes.
198 oplasty and 6,703 patients who underwent hip arthroplasty over a 5-year period were analyzed.
199 d function score, modestly favored total hip arthroplasty over hemiarthroplasty.
200 lgesic or antiinflammatory drugs, and having arthroplasty (P < 0.001).
201 r antiinflammatory use but decreased odds of arthroplasty (P < 0.01).
202          The proportion of primary total hip arthroplasty patients discharged home declined from 68.0
203 ncy and safety of steroids with MCPI in knee arthroplasty patients during the early postoperative per
204 hrombocytopenia: one following shoulder hemi-arthroplasty (performed without heparin) and the other p
205               Among patients undergoing knee arthroplasty, postoperative osocimab 0.6 mg/kg, 1.2 mg/k
206 ion for cervical spine surgery or total knee arthroplasty (primary and revision), although in 1998-20
207        Advances concerning bone grafting and arthroplasty procedures have resulted in improved clinic
208 ived for bacterial culture from 198 revision arthroplasty procedures, we retrospectively determined t
209 s, including cardiac bypass and hip and knee arthroplasty procedures.
210 d to undergo hemiarthroplasty, and total hip arthroplasty provided a clinically unimportant improveme
211 onitored home-based program after total knee arthroplasty provided greater improvements than a monito
212 tributed to racial and ethnic disparities in arthroplasty rates.
213 llograft bone donated from primary total hip arthroplasty recipients must be discarded or treated to
214                 A vast majority (83%) of hip arthroplasty recipients were women.
215 ening urine cultures prior to elective joint arthroplasty resulted in substantial reduction in urine
216   One hundred thirty-six patients undergoing arthroplasty revision or resection were studied; 33 had
217 f infection-related complications after knee arthroplasty (RR 1.64, 95% CI 1.08-2.49) relative to oth
218 tic joint prosthesis loosening (septic total arthroplasty [SeTA]; 9 specimens), rheumatoid arthritis
219  Our in-hospital mortality data suggest that arthroplasties should not be denied to centenarians sole
220                       For revision total hip arthroplasty, similar trends were observed in hospital L
221 ces made by the silicone metacarpophalangeal arthroplasty (SMPA) group regarding hand reconstruction
222 ilms dislodged from the surfaces of resected arthroplasties (sonicate fluid).
223 rom tissue donors and OA cartilage from knee arthroplasty specimens.
224  18 to 90 years undergoing total knee or hip arthroplasty; spine surgery; coronary artery bypass graf
225  Exercise participation prior to total joint arthroplasty substantially reduced the risk of discharge
226 durable FICS undergoing definitive total hip arthroplasty surgery because of local tumor progression.
227 w of 0.005 for "Procedure-Targeted Total Hip Arthroplasty Surgical Site Infection." Generally, reliab
228 ports the safety and efficacy of total-ankle arthroplasty (TAA).
229 parameters and the 19-year risk of total hip arthroplasty (THA) for end-stage OA.
230 ing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the facto
231  predictors of prognosis following total hip arthroplasty (THA) for osteoarthritis (OA).
232 t included 556 patients undergoing total hip arthroplasty (THA) from December 2015 to October 2017.
233 -day readmission to hospital after total hip arthroplasty (THA) has significant direct costs and is u
234              Offset restoration in total hip arthroplasty (THA) is associated with postoperative rang
235 spirin in thromboprophylaxis after total hip arthroplasty (THA) is controversial.
236 of 108 men and women scheduled for total hip arthroplasty (THA) or total knee arthroplasty (TKA) were
237 itals' SSI rates following primary total hip arthroplasty (THA) or total knee arthroplasty (TKA).
238 he preferred surgical approach for total hip arthroplasty (THA).
239 ortance in assessment of pain with total hip arthroplasty (THA).
240 slocation and aseptic loosening in total hip arthroplasty (THA).
241 roplasty, corresponding to an annual risk of arthroplasty that was about six times that of the genera
242 n muscle of patients who were undergoing hip arthroplasty, the 14-kD actin fragment level was correla
243 g adults undergoing uncomplicated total knee arthroplasty, the use of inpatient rehabilitation compar
244 xplain disparities in the use of total joint arthroplasty (TJA).
245 udies on rehabilitation following total knee arthroplasty (TKA) demonstrated limited efficacy in incr
246                                   Total knee arthroplasty (TKA) is one of the most common and costly
247                                   Total knee arthroplasty (TKA) is one of the most successful orthopa
248 provides convincing evidence that total knee arthroplasty (TKA) is safe and improves joint-specific o
249 ugh frequently observed following total knee arthroplasty (TKA) no therapeutic options exist.
250                                   Total knee arthroplasty (TKA) periprosthetic joint infection (PJI)
251 r total hip arthroplasty (THA) or total knee arthroplasty (TKA) were randomized to a 6-week exercise
252 ynovial patterns in patients with total knee arthroplasty (TKA), whether diagnostic accuracy differs
253 y total hip arthroplasty (THA) or total knee arthroplasty (TKA).
254 . adults are projected to undergo total knee arthroplasty (TKA).
255 nal trends in the epidemiology of total knee arthroplasty (TKA).
256 en used for local infiltration in total knee arthroplasty (TKA).
257 odel of surgery-induced fibrosis, total knee arthroplasty (TKA).
258 s from assessment (range: 42% for total knee arthroplasty to 96% for laparoscopic cholecystectomy).
259 as similar between time intervals from index arthroplasty to DAIR: the failure rate for Week 1-2 was
260 as similar between time-intervals from index arthroplasty to DAIR: week 1-2: 42% (95/226); week 3-4:
261 going elective primary unilateral total knee arthroplasty to receive one of two doses of FXI-ASO (200
262  abdominal aortic aneurysm repair, total hip arthroplasty, total knee arthroplasty, and lung resectio
263 plasty (TPKA) and after total or partial hip arthroplasty (TPHA) are proposed patient safety indicato
264 boembolism (VTE) after total or partial knee arthroplasty (TPKA) and after total or partial hip arthr
265 m femoral heads of patients undergoing joint arthroplasty) treated with MOFs crystals suggested that
266                    The Total or Partial Knee Arthroplasty Trial (TOPKAT) therefore aims to assess the
267 idemiology and utilization of total shoulder arthroplasty (TSA) have not been previously reported.
268 vs 42 days (IQR, 21-114 days) following knee arthroplasty (unadjusted hazard ratio [HR], 1.60; 95% co
269 ilms dislodged from the surface of explanted arthroplasties using vortexing and sonication (i.e., son
270 y 2005 to August 2009, including colorectal, arthroplasty, vascular, and gynecologic procedures.
271 proctectomy, hysterectomy, total hip or knee arthroplasty, ventral hernia repair, and lower extremity
272 rtile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following kne
273                  Median age at time of first arthroplasty was 20.1 years (range, 15.1 to 35.4 years).
274 going elective primary unilateral total knee arthroplasty was an effective method for its prevention
275  the national level, the annual rate of knee arthroplasty was higher for non-Hispanic white women (5.
276 sk of hospitalization for primary total knee arthroplasty was significantly lower in 1998-2001 than i
277                     Overall, 23 (3.7%) joint arthroplasties were complicated by an infection during a
278  Participants reported hospitalizations, and arthroplasties were identified by procedure codes.
279                      A total of 430,726 knee arthroplasties were performed during the three-year stud
280 ctrotherapy and acupuncture after total knee arthroplasty were associated with reduced and delayed op
281                             Women with prior arthroplasty were excluded, yielding a sample size of 26
282                   Rates of total knee or hip arthroplasty were found to be substantially lower among
283 d infection-related complications after knee arthroplasty were higher among black patients compared w
284 ars) undergoing elective primary hip or knee arthroplasty were postoperatively assessed for delirium
285    Adult patients undergoing unilateral knee arthroplasty were randomized from October 2017 through A
286 ents scheduled to undergo elective total hip arthroplasty were randomly assigned, stratified accordin
287 Patients with OA receiving total hip or knee arthroplasty were recruited and completed two sets of st
288 rthroplasty and 28 patients with noninfected arthroplasty were reviewed by two musculoskeletal radiol
289       Candidates for total hip or total knee arthroplasty were reviewed in a multicenter cohort study
290 osteoarthritis undergoing primary total knee arthroplasty were screened for eligibility.
291 alized infection, PJI, and readmission after arthroplasty were similar across biologics.
292  of the reconstructive procedures-fusion and arthroplasty-were highly correlated in each state, but t
293 iewed in a cohort of 58 patients with 66 hip arthroplasties with Rejuvenate stems who had presented f
294 t and retention of the prosthesis, resection arthroplasty with or without subsequent staged reimplant
295 rgery with post-operative rehabilitation, or arthroplasty with post-operative rehabilitation.
296 ing knee arthroplasty and 0.7% following hip arthroplasty, with no significant differences by race/et
297 amputation, arthroplasty) within 1 year, and arthroplasty within 15 years were determined.
298 rse joint outcomes (arthrodesis, amputation, arthroplasty) within 1 year, and arthroplasty within 15
299 a recovered at the time of revision shoulder arthroplasty would often represent more than one subtype
300 A) are at increased risk for infection after arthroplasty, yet risks of specific biologic medications

 
Page Top